Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients

ClinicalTrials.gov ID: NCT00044070

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00044070. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 2:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Effects of YM872 on Lesion Volume as Measured by Diffusion, Perfusion, and FLAIR Magnetic Resonance Imaging in Patients With Acute Ischemic Stroke

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will investigate the effects of a potential neuroprotectant compound, YM872, in the treatment of acute ischemic stroke. The study will determine if a 24-hour infusion of YM872, given within 6 hours of stroke onset, reduces the ischemic lesion volume as measured by MRI at 28 days after the infusion is given. The clinical effects of YM872 will also be determined by neurological function and disability scores at follow up visits through Day 90 of the study.

Study identification

NCT ID
NCT00044070
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2000 (Type not available)
Primary completion
Not listed
Completion
Jan 2003 (Type not available)
Last update posted
Apr 3, 2006

2000 – 2003

United States locations

U.S. sites
60
U.S. states
26
U.S. cities
56
Facility City State ZIP Site status
University of South Alabama Stroke Center Mobile Alabama — —
Phoenix Neurology Associates (Good Samaritan Hospital) Phoenix Arizona — —
University of Arizona Tucson Arizona — —
Providence St. Joseph's Medical Center Burbank California — —
Grossmont Hospital La Mesa California — —
UCLA Emergency Medical Center Los Angeles California — —
Good Samaritan Hospital San Jose California — —
Santa Monica UCLA Medical Center Santa Monica California — —
John Muir Medical Center Walnut Creek California — —
Bridgeport Hospital Bridgeport Connecticut — —
Bethesda Memorial Hospital Boynton Beach Florida — —
Holmes Regional Medical Center Melbourne Florida — —
University of Miami (Jackson Memorial Hospital) Miami Florida — —
Florida Neurovascular Institute Tampa Florida — —
DNA Research (Dekalb Medical Center) Decatur Georgia — —
OSF St. Francis Medical Center Peoria Illinois — —
Parkview Hospital Fort Wayne Indiana — —
University of Kentucky Lexington Kentucky — —
Louisville Neuroscience Research Center Louisville Kentucky — —
Cullicchia Neurology Clinic, LLP Marrero Louisiana — —
Johns Hopkins Medical Institute Baltimore Maryland — —
Beth Israel Deaconess Medical Center Boston Massachusetts — —
New England Medical Center Boston Massachusetts — —
Wayne State University Detroit Michigan — —
Michigan State University East Lansing Michigan — —
William Beaumont Hospital Royal Oak Michigan — —
Field Neurosciences Institute (St. Mary's Hospital) Saginaw Michigan — —
Advanced Neurology Specialists (Benefis Healthcare Hospital) Great Falls Montana — —
St. Patrick's Hospital & Health Sciences Center Missoula Montana — —
Washoe Comprehensive Stroke Center Reno Nevada — —
JFK Medical Center Edison New Jersey — —
Neurology Group of Bergen County (Valley Hospital) Ridgewood New Jersey — —
University of New Mexico Hospital Albuquerque New Mexico — —
VA Medical Center Albuquerque New Mexico — —
Albany Medical Center Albany New York — —
Buffalo General Hospital Buffalo New York — —
North Shore University Hospital Manhasset New York — —
Long Island Jewish Medical Center New Hyde Park New York — —
St. Luke's Hospital New York New York — —
Ellis Hospital Schenectady New York — —
Stony Brook Hospital Stony Brook New York — —
All-Trials Clinical Research, LLC (Rowan Regional Medical Center) Winston-Salem North Carolina — —
Metrohealth Medical Center Cleveland Ohio — —
Riverside Methodist Hospital Columbus Ohio — —
Medical College of Ohio Toledo Ohio — —
St. Elizabeth Health Center Youngstown Ohio — —
Hershey Medical Center Hershey Pennsylvania — —
University of Pittsburgh Medical Center Stroke Institute Pittsburgh Pennsylvania — —
Chattanooga Neurology Associates (Erlanger Hospital) Chattanooga Tennessee — —
Chattanooga Neurology Associates (Memorial Hospital) Chattanooga Tennessee — —
St. Thomas Hospital Nashville Tennessee — —
Vanderbilt University Medical Center Nashville Tennessee — —
University of Texas (Houston Medical Center) Houston Texas — —
Neurology Associates, Inc. (St. Mary's Hospital) Richmond Virginia — —
Virginia Beach General Hospital Virginia Beach Virginia — —
Stevens Memorial Hospital Edmonds Washington — —
Providence St. Peter Hospital Olympia Washington — —
Sacred Heart Medical Center Spokane Washington — —
St. Luke's Medical Center Milwaukee Wisconsin — —
Theda Clark Medical Center Neenah Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00044070, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 3, 2006 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.